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Abstract
Adenocarcinoma of the esophagus has increased dramatically within the United States and
continues to have a poor prognosis despite aggressive treatment. Identifying potential risk factors
is critical for the early detection and treatment of this disease. The present case report describes
a very young woman who developed adenocarcinoma of the esophagus after only a brief history of
bulimia. These findings suggest that even in very young patients, bulimia may represent a risk factor
for adenocarcinoma of the esophagus.
Introduction
In the past twenty-five years, the prevalence of esophageal
adenocarcinoma has increased dramatically within the
United States and it is now the most common histological
type of esophageal cancer [1]. Despite advances in treat-
ment, adenocarcinoma of the esophagus has a poor prog-
nosis [2]. A recent study of patients with resectable disease
demonstrated 5 year overall survivals of 81%, 51%, 14%,
and 0% for stage I through IV respectively [3]. Previously
implicated risk factors for esophageal adenocarcinoma
include gastroesophageal reflux disease, tobacco use,
obesity, and Barrett's esophagus. Prior reports have also
suggested that chronic bulimia nervosa (BN) is a risk fac-
tor for the development of esophageal adenocarcinoma.
Repeated microtrauma, due to vomiting, may contribute
to the malignant transformation of the esophageal tissue.
We report the case of a 27 year old female patient with a
remote history of BN recently diagnosed with adenocarci-
noma of the esophagus.
Case presentation
A 27 year old female presented with a one year history of
progressively worsening epigastric pain, reflux, and
fatigue. She was initially treated with acid suppression
therapy by her primary care physician, which temporarily
relieved her symptoms. However, her symptoms became
refractory to medication and she noted the onset of dys-
phagia. She reported a remote history of bulimia nervosa
(BN) of approximately one year duration at the age of 17.
She reported episodes of binge eating and self-induced
vomiting, at least once a day. She denied any further his-
tory of bulimia since that time, which was corroborated
by her mother. The patient reported smoking approxi-
mately 10 cigarettes per day since the age of 20, and had
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recently quit. She denied alcohol and drug abuse, and had
no family history of malignancy.
On physical examination the patient's weight was 102 lbs
(BMI 18.7). There were no physical findings suggestive of
chronic bulimia such as dorsal finger calluses, dental ero-
sion, or parotid enlargement. She denied recent weight
loss. The patient had mild epigastric tenderness on palpa-
tion of the abdomen. The remainder of her examination
was within normal limits. Routine laboratory tests were
normal
Upper gastrointestinal endoscopy revealed a 10 mm ulcer-
ated lesion with diffuse erythema near the gastroesopha-
geal (GE) junction (Figure 1). Biopsies from this area
demonstrated poorly differentiated adenocarcinoma (Fig-
ure 2). Endoscopic ultrasound revealed a 20 mm × 20
mm, hypoechoic, non-circumferential mass at the GE
junction with evidence of serosal invasion, but no nodal
disease. CT scan revealed no evidence of nodal or meta-
static disease. The patient was clinically staged as having
T3 N0 M0 disease (Stage IIa).
The patient elected to undergo neoadjuvant chemoradia-
tion with oxaliplatin, 5-FU, and Cetuximab with concur-
rent radiation to a dose of 5040 cGy. She had j-tube
placement prior to treatment. She required one admission
for fluids and nutritional support during treatment. Six
weeks after completing neoadjuvant chemoradiation she
underwent an Ivor Lewis esophagectomy, during which a
right ovarian mass was noted and biopsied. Frozen sec-
tion revealed metastasis and a right oophorectomy was
performed. Pathology revealed signet ring cell adenocarci-
noma of the GE junction and ovary, three positive gastric
lymph nodes and three negative esophageal nodes. She
then received adjuvant chemotherapy with epirubicin, cis-
platin and capecitabine for six cycles. The patient was then
followed regularly every three months with CT imaging.
Interval evaluation at twelve months after diagnosis, five
months after completing adjuvant chemotherapy, dem-
onstrated no evidence of disease. Unfortunately, CT per-
formed thirteen months after diagnosis demonstrated
interval development of pleural effusions, ascities and a
large pelvic mass, likely arising from the left ovary, con-
sistent with recurrent metastatic disease.
Biopsy from endoscopy Figure 2
Biopsy from endoscopy. High power and low power 
images from endoscopic biopsy are shown above. Invasive 
adenocarcinoma and glandular metaplasia can be seen 
beneath the intact squamous epithelium on the lower power 
image. Signet rings (red arrows) are seen in the higher power 
image.
Endoscopy Figure 1
Endoscopy. Shown is a small 10 mm ulcerated lesion at the 
GE junction (blue arrow) seen on endoscopy.Journal of Medical Case Reports 2007, 1:160 http://www.jmedicalcasereports.com/content/1/1/160
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Discussion
The present case report demonstrates the importance of
diagnosing esophageal cancer early, particularly in young
patients, as advanced disease carries a devastating progno-
sis. Previous studies have demonstrated an associated
between adenocarcinoma of the esophagus and reflux [4],
the length and severity of reflux [5], and drugs which relax
the lower esophageal sphincter [6]. These studies have
suggested up to a 44 fold increase in the risk of developing
adenocarcinoma of the esophagus with severe reflux and
a 30–125 fold increase in risk in patients with Barrett's
esophagus [7]. It appears family history is not strongly
associated with the risk of developing esophageal cancer
[8]. In the case of our patient there was no history of
chronic reflux disease, with reflux symptoms only arising
near the time of diagnosis. Furthermore, she had limited
exposure to cigarettes and alcohol, which are more com-
monly associated with squamous cell carcinomas of the
esophagus. Given the lack of other risk factors, it seems
reasonable to consider her history of bulimia as a possible
risk factor for her cancer. Similar to chronic reflux,
bulimia may cause chronic irritation and trauma to the
esophagus leading to dysplasia and ultimately tumorgen-
esis.
It is difficult to determine BN's exact prevalence due to
changes in definition and difficulty in obtaining accurate
responses in surveys, but it appears to be about 2% [9].
Esophagitis and Barrett's esophagus are known complica-
tions of BN [10], however only a few cases of esophageal
cancer arising in patients with BN have been reported.
Two cases of women in their 30's with a history of BN who
developed esophageal cancer have been reported but no
further details were provided [11]. Another case report
described a young male patient with adenocarcinoma of
the cervical esophagus who had a history of BN and alco-
hol abuse [12]. Endoscopy demonstrated extensive Bar-
rett's esophagus and high grade dysplasia of the entire
esophagus with superimposed candidial infection. A
patient with longstanding BN who developed adenocarci-
noma of the stomach has also been reported [13].
Another case report describes a 42 year old woman with a
history of BN, without a history of smoking or drinking,
who developed squamous cell carcinoma (SCC) of the
distal esophagus [14]. These reports are summarized in
(Table 1). The present case report describes a 27 year old
female with a remote history of BN, which was of short
duration, who was subsequently diagnosed with adeno-
carcinoma of the esophagus. This patient is unique for a
number of reasons including her young age and the rela-
tively short history of bulimia, which was significantly less
severe than prior case reports.
Conclusion
Studies suggest that there are long delays in the diagnosis
of esophageal cancer [15]. Determining which factors put
a patient at increased risk is critical as advanced disease
has a poor prognosis. Esophageal cancer is most prevalent
among older patients; however BN may represent an
important risk factor in younger patients. Several prior
case reports describe patients who were diagnosed at a
young age (Table 1). This suggests that endoscopy may be
warranted in younger patients with BN who present with
new onset of persistent pain, weight loss, odynophagia or
dysphagia. The course of the present patient suggests that
even a remote, short history of BN may increase the risk
for adenocarcinoma of the esophagus.
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